Study examines strength of evidence of drugs granted 'breakthrough' approval

(JAMA Network) The US Food and Drug Administration (FDA) created the Breakthrough Therapy designation in 2012 to expedite the development and review of drugs and biologics intended to treat serious or life-threatening conditions when preliminary clinical evidence suggested better improvement over existing therapies.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2zP3twA